Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study

被引:0
|
作者
Artemis Koutsonikoli
Maria Trachana
Anna-Bettina Heidich
Vasiliki Galanopoulou
Polyxeni Pratsidou-Gertsi
Alexandros Garyphallos
机构
[1] Aristotle University,1st Department of Pediatrics, Pediatric Immunology and Rheumatology Referral Center, Hippokration Hospital
[2] Aristotle University,Department of Hygiene and Epidemiology
[3] Papageorgiou Hospital,Rheumatology Department
[4] Aristotle University,4th Department of Internal Medicine, Hippokration Hospital
来源
关键词
Childhood Lupus; Damage; SDI;
D O I
暂无
中图分类号
学科分类号
摘要
The improved survival of childhood-onset systemic lupus erythematosus (cSLE) has resulted in longer patients’ exposure to disease inflammation, medications and/or comorbid diseases, which can all contribute to the development of organ damage. The aim of this study was to assess the evolution of damage accrual in cSLE patients overtime and investigate for predisposing factors. Disease characteristics and treatment in 47 Northern Greek Caucasian cSLE patients were retrospectively reviewed. The Systemic Lupus International Collaboration Clinics/American College of Rheumatology Damage Index (SDI) was used for damage assessment and the European Consensus Lupus Activity Measurement (ECLAM) to monitor cSLE activity. After a median disease duration of 7.4 years, 17/47 patients (36 %) had developed damage (SDI > 0). The most frequent domains damaged were the ocular (41 %), neuropsychiatric (35 %) and peripheral vascular (35 %) one. Peripheral vascular and neuropsychiatric damage was seen more frequently during the first 5 years of the disease. Longer exposure to azathioprine was associated with higher SDI at the end of follow-up (β = 0.008 for every additional month of use, p = 0.041). The mean annual flare frequency was associated with a shorter time interval until the development of the first damage (hazard’s ratio, HR 2.38 for each unit of increase, p = 0.018), while hydroxychloroquine use was associated with longer time interval (HR 0.19, p = 0.007). The lower rates of damage accrual in this study compared to other cohorts might be due to milder disease phenotype in Greek Caucasian cSLE patients, prompt diagnosis and effective disease control. Damage was noticed early in the disease course, and one-third of patients had an SDI > 0 at study completion. Disease flares and a severe disease course leading to prolonged use of immunosuppressives were significant risk factors, while hydroxychloroquine use was protective against cSLE damage accrual.
引用
收藏
页码:1225 / 1232
页数:7
相关论文
共 50 条
  • [11] Evaluation Of Quality Indicators and Disease Damage In Childhood-Onset Systemic Lupus Erythematosus Patients
    Harris, Julia G.
    Maletta, Kristyn I.
    Kuhn, Evelyn M.
    Olson, Judyann C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S534 - S534
  • [12] Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients
    Harris, Julia G.
    Maletta, Kristyn I.
    Kuhn, Evelyn M.
    Olson, Judyann C.
    CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 351 - 359
  • [13] Evaluation of Quality Indicators and Disease Damage in Childhood-Onset Systemic Lupus Erythematosus Patients
    Harris, Julia G.
    Maletta, Kristyn I.
    Kuhn, Evelyn M.
    Olson, Judyann C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S214 - S214
  • [14] Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients
    Julia G. Harris
    Kristyn I. Maletta
    Evelyn M. Kuhn
    Judyann C. Olson
    Clinical Rheumatology, 2017, 36 : 351 - 359
  • [15] Childhood-onset bullous systemic lupus erythematosus
    Lourenco, D. M. R.
    Gomes, R. Cunha
    Aikawa, N. E.
    Campos, L. M. A.
    Romiti, R.
    Silva, C. A.
    LUPUS, 2014, 23 (13) : 1422 - 1425
  • [16] Revisiting Childhood-Onset Systemic Lupus Erythematosus
    Avar-Aydin, Pinar Ozge
    Brunner, Hermine I.
    TURKISH ARCHIVES OF PEDIATRICS, 2024, 59 (04): : 336 - 344
  • [17] Symptom clustering in patients with childhood-onset systemic lupus erythematosus
    Chiang, Yi-Chien
    Huang, Jing-Long
    Wang, Chao-Hui
    Lee, Hsiang-Chun
    Lee, Ming-Ying
    Hsiao, Ya-Chu
    JOURNAL OF ADVANCED NURSING, 2019, 75 (01) : 54 - 62
  • [18] Childhood-Onset Disease as a Predictor of Mortality in an Adult Cohort of Patients With Systemic Lupus Erythematosus
    Hersh, Aimee O.
    Trupin, Laura
    Yazdany, Jinoos
    Panopalis, Peter
    Julian, Laura
    Katz, Patricia
    Criswell, Lindsey A.
    Yelin, Edward
    ARTHRITIS CARE & RESEARCH, 2010, 62 (08) : 1152 - 1159
  • [19] Childhood-onset systemic lupus erythematosus: an update
    Borgia, Roberto Ezequiel
    Silverman, Earl D.
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (05) : 483 - 492
  • [20] Biomarkers in Childhood-Onset Systemic Lupus Erythematosus
    Cody, Ellen M.
    Brunner, Hermine, I
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2022, 48 (01) : 271 - 285